Official Side Events
Speaker & Facilitator Biographies
Dr. Mohannad Al Nsour
Executive Director, EMPHNET
Dr. Mohannad Al-Nsour is a medical doctor and an internationally recognized expert in field epidemiology, operational research, and public health systems. Dr. Al-Nsour assumed several positions such as a notable researcher, advisor, and director during his career path. He also served as a consultant on several assignments with the US Centers for Disease Control and Prevention, the World Health Organization, and the American University of Beirut. Dr. Al-Nsour has been leading the Eastern Mediterranean Public Health Network (EMPHNET) since 2009, by providing strategic assistance and operational solutions, and guiding the enrichment of Field Epidemiology Training Programs (FETPs) and public health initiatives in the region. Under Dr. Al Nsour’s leadership, GHD|EMPHNET emerged as a prominent collaborative platform to serve the region and support national efforts to promote public health policies, applied epidemiology, surveillance, International Health Regulations (IHR), resource mobilization, and public health program development among others. Dr. Al-Nsour is a lecturer and speaker at regional and international levels covering public health topics such as leadership, field epidemiology, delivering evidence-based recommendations, creating new opportunities, and being a catalyst for change. Some of his areas of expertise are infectious diseases, non-communicable diseases (NCD), and global health. Dr. Al-Nsour serves on several regional and global initiatives, associations and networks as he is a member of the Steering Committee for the Global Outbreak Alert and Response Network (GOARN), Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET), International Epidemiological Association, and more. He is currently leading the establishment of the Public Health Forum and the NCD Alliance in Jordan.
Senior Vice President, Global Health Division, Chemonics
Julie Becker is currently the senior vice president of Chemonics’ Global Health Division where she leads the division’s strategy and growth and its work in health systems strengthening, HIV, malaria and private sector engagement, among other areas. Ms. Becker has more than 30 years of global health experience in the nonprofit and private sectors, and has worked on the ground in sub-Saharan Africa, Asia, Latin America, the Caribbean, and the US. Prior to Chemonics, she served as an executive vice president at Rabin Martin, where she led the firm’s program practice and vaccine work, primarily supporting private sector companies and the Gates Foundation. Ms. Becker also directed a team leading the design of a portfolio of investments for Merck for Mothers, a large-scale corporate responsibility initiative to reduce the burden of maternal mortality around the world. Earlier in her career, she led vaccine preparedness across five countries for the International AIDS Vaccine Initiative, and a portfolio of innovative country and global programs to integrate HIV and family planning/maternal health at EngenderHealth and IPPF. Ms. Becker has a Sc.M. in public health, behavioral science from the Harvard School of Public Health.
Dr. Beth Cameron
Special Assistant to the President & Senior Director, Global Health Security and Biodefense, National Security Council
Beth Cameron currently serves as Special Assistant to the President and Senior Director for Global Health Security and Biodefense on the White House National Security Council (NSC) staff. Prior to her recent appointment, Beth was the vice president for global biological policy and programs at NTI.
Cameron previously served as the senior director for global health security and biodefense on the White House NSC staff, where she was instrumental in developing and launching the Global Health Security Agenda and addressed homeland and national security threats surrounding biosecurity and biosafety, biodefense, emerging infectious disease threats, biological select agents and toxins, dual‐use research, and bioterrorism.
From 2010‐2013, Cameron served as office director for Cooperative Threat Reduction (CTR) and senior advisor for the Assistant Secretary of Defense for nuclear, chemical and biological defense programs. In this role, she oversaw implementation of the geographic expansion of the Nunn‐Lugar CTR program. For her work, she was awarded the Office of the Secretary of Defense Medal for Exceptional Civilian Service.
From 2003‐2010 Cameron oversaw expansion of Department of State Global Threat Reduction programs and supported the expansion and extension of the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction, a multilateral framework to improve global CBRN security.
Cameron served as an American Association for the Advancement of Science (AAAS) fellow in the health policy office of Senator Edward M. Kennedy where she worked on the Patients’ Bill of Rights, medical privacy, and legislation to improve the quality of cancer care. From 2001‐2003, she served as a manager of policy research for the American Cancer Society.
Cameron holds a Ph.D. in Biology from the Human Genetics and Molecular Biology Program at the Johns Hopkins University and a BA in Biology from the University of Virginia. Cameron is a member of the Council on Foreign Relations.
President & CEO, Friends of the Global Fight
At Friends of the Global Fight Chris played a central role in two major global health financing wins: in 2019, achieving the first increase in U.S. support to the Global Fund in six years; and, in 2020 and 2021, approval of $3.5 billion in emergency COVID-19 funding for the Global Fund, the largest ever single U.S. appropriation to the organization. Previously, Chris was Chief of the Community Mobilization Division at UNAIDS, Vice President and Director of Public Policy at amfAR, and executive director at AVAC. Chris authored the monograph that inspired the effort to create the first comprehensive US National HIV/AIDS Strategy. As appropriations staff to Rep. Nancy Pelosi (D-CA) in the late 1990s, Chris designed the first legislation to provide incentives for development and delivery of vaccines against HIV, tuberculosis and malaria.
Director, U.S. Strategy, Gavi
Chief Executive Officer, NCD Alliance
Ms Dain has worked with the NCD Alliance since its founding in 2009. Her experience has included organisational and strategic development, global advocacy and policy-making, and program design and capacity-building in low- and middle-income countries.
Ms Dain is widely recognised as a leading advocate and expert on non-communicable diseases (NCDs), and has authored or co-authored numerous papers and commentaries on global health and development policy issues. She is a member of advisory groups and committees for a range of international NCD initiatives, including being a member of the Lancet Commission on Noncommunicable Diseases and Injuries of the Poorest Billion. Before joining the NCD Alliance, Ms Dain worked at the International Diabetes Federation (IDF) in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
Prior to that, she held a series of policy posts in the UK Government and UK-based health and development non-government organisations, including Gender Policy Adviser to the UK Government Equalities Office (GEO), where she was responsible for strategy and policy on violence against women; Womankind Worldwide, a women’s rights organisation; and Terrence Higgins Trust, an HIV and sexual health charity.Ms Dain has a Master’s degree in Violence, Conflict and International Development from the School of Oriental and African Studies (SOAS), London.
Dr. Lola Dare
President, CHESTRAD Global
Lola Dare is an award winning community physician, epidemiologist, public health practitioner, development consultant, sociopreneur and irrepressible global health advocate for women, girls, young persons for over 30 years. She has championed the application of evidence and data for policy, evaluation and accountability demand functions of a broad range of non-state actors including civil society and community based organizations, private sector and the media. Lola has been in the forefront of advocacy for resilient, accountable right based health care services and systems strengthening. She has engaged policy makers, parliamentarians, large donor funded programmes and national governments including bilateral, multi-lateral and intergovernmental organizations and agencies. At country, regional and global levels, Lola has nimbly linked investments in health to social protection, with resultant multi-sector actions for large scale impact.
Lola Dare is an innovative thought leader whose voice is well respected as informed and authentically southern in global, regional and national level dialogues on health and development. She is President of Chestrad Global, a trail-blazing, award winning global social enterprise. Formerly known as CHESTRAD, Chestrad Global has grown from an indigenous research firm into an African-led social enterprise with significant influence in global health and development.
Lola Dare’s impact on global health, management, leadership and development at all levels is expansive. Her effort has resulted in I Will Give Africa (IWG), a novel platform that seeks to positively disrupt traditional norms of development financing, focusing on not only financial inclusion for women and young people, but also expanding domestic financing for health and development from public budgets and more.
She has served in many roles in governance mechanisms of international agencies including the US National Academies for Science, Engineering and Medicine (NASEM), Global Fund for Malaria, Tuberculosis and HIV/AIDS, Gavi, Partnership for Maternal and Child Health (PMNCH), , High Level Task Force on ICPD Beyondv2015, the Lancet, WHO technical teams and agencies of the United Nations, African Union and African continental organizations. Lola-Dare brings passion, competence and far-reaching knowledge of much needed country context to development dialogues with a unique capacity to deploy innovation and fresh thinking. Lola has been awarded membership of the UK Based Game Changers Women’s Leadership network with recognition on its Wall of Wonder Women. She is a member of the Transition Independent Monitoring Board (TIMB), Global Polio Eradication Initiative (GPEI) and the RBM Partnership to End Malaria.
Lola Dare is a graduate of the College of Medicine University of Ibadan, Nigeria. She holds a Master’s of Science degree in Epidemiology; with a bias for statistics (London School of Hygiene and Tropical Medicine); awarded certificates in Population and Development and International Health as David E. Bell and Takemi Fellow of the Harvard School of Public Health, USA; and in Advance Management from INSEAD, the prestigious European Business School, France. Dr Dare is a member of the West African Postgraduate Medical College, Faculty of Public Health and fellow of the Nigerian National Postgraduate Medical College, Faculty of Community Medicine. She is a Fellow, by distinction, of the Faculty of Public Health, United Kingdom, a joint Faculty of the Royal Colleges of Physicians, (London, Edinburgh and Glasgow). She served for many years as its Overseas Regional Adviser for Africa. Lola Dare is published beyond her immediate spheres of influence and well awarded for her work.
Dr. Roopa Dhatt
Executive Director, Women in Global Health
Dr. Roopa Dhatt is a passionate advocate for gender equality in global health and a leading voice in the movement to correct the gender imbalance in global health leadership. She is also a practicing Internal Medicine physician in Washington, D.C. Dr. Dhatt is particularly committed to addressing issues of power, privilege, and intersectionality that keep many women from global health leadership roles and to opening up spaces for the voices of these women. Determined to transform women’s leadership opportunities in health, Dr. Dhatt co-founded Women in Global Health in 2015. Today, Women in Global Health has 40 official chapters, more than 50,000 supporters in more than 90 countries, and continues to grow. As Executive Director, she and the global team work together with a network of WGH chapters in every region to challenge power and privilege for gender equity in health. Dr. Dhatt has worked in global health for 15 years, collaborating with 120+ countries. She holds numerous advisory and board roles. She has published in the Lancet, BMJ, Devex, Forbes, and been interviewed in National Geographic, Nature, NPR, EuroNews, and more. Dr. Dhatt was recognized in Gender Equality Top 100, the most influential people in global policy 2019. She was invited as a public delegate to the historic United States Government Delegation to the United Nations 65th Commission of Status of Women Meeting in March 2021 and is a member of the Lancet COVID-19 Commission, Global Health Diplomacy and Cooperation Task Force
Director, Global Partnerships & Strategy, MSH
Olumide O. Elegbe is currently the Director of Global Partnerships & Strategy at MSH. He first joined MSH in 2016 as Senior Manager, Corporate and Foundation Relations, working extensively with the private sector to create new partnerships. Elegbe was later appointed Country Representative in Nigeria with a focus on business development, partnerships, and compliance. And in 2019, he was promoted to Portfolio Director, also serving as Director of the pilot division for Global Fund programs and managing operations in the Nigeria country office. Prior to joining MSH, Elegbe served as Associate Director for Partnerships and Senior Strategy Analyst with FHI360, as a public health specialist with the UK National Health Service, and as a consultant on public health assignments in Europe and sub-Saharan Africa. Elegbe speaks Yoruba and Russian fluently, holds a Masters in Public Health in Health Services Management from the London School of Hygiene &Tropical Medicine, and a certificate from Harvard Business School.
Dr. Ngozi Erondu
Infectious Disease Epidemiologist and Global Health Policy Expert
I currently work as a Senior Research Fellow at the Chatham House Centre for Global Health Security and a Senior Public Health Advisor at Public Health England. I am a 2017 Aspen Institute New Voices Fellow.
I am essentially an operational researcher. I have 10 years experience in epidemiology and program evaluation. Several of those years spent doing fieldwork on the surveillance of various epidemic prone or vaccine preventable diseases: I worked in Kenya on poliomyelitis, Saudi Arabia on H1N1, Chad on meningococcal meningitis, and Guinea on Ebola Virus Disease.
I am also very interested in finding where the ‘weak links’ are in our global health system and finding out what does it takes to strengthen them. I coordinated a DFID-funded study to increase the use of data for malaria decision-making in 14 high-burden malaria countries in sub-Saharan Africa. I also worked with the WHO on developing a costing tool for the International Health Regulations (2005) and with several countries to evaluate their disease surveillance systems.
These experiences have translated into a passion that I have for global health reform—through policy, through improved funding mechanisms, and through expanding the field of experts.
Dr. Satoshi Ezoe
Director, Global Health Policy Division, Ministry of Foreign Affairs, Japan
SATOSHI EZOE is the director of the Global Health Policy Division at the Ministry of Foreign Affairs (MOFA). Prior to this, he was in charge of global health as the Counsellor at the Permanent Mission of Japan to the United Nations in New York. He started his career at the Ministry of Health, Labour and Welfare (MHLW) of Japan in 2002 and since has worked on various issues as Medical Officer as well as Global Health Coordinator. In 2009–2012, he was seconded to the UNAIDS. Dr. Ezoe holds a PhD in Public Health from Juntendo University, an MD from National Saga Medical School, and an MPA/MPH in Global Health from Harvard Kennedy School.
Dr. Paul Farmer
Co-Founder and Chief Strategist, Partners in Health
Paul Farmer, M.D., Ph.D., is Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, chief of the Division of Global Health Equity at Brigham and Women’s Hospital in Boston, and Co-founder and chief strategist of Partners In Health. Farmer and his colleagues have pioneered novel, community-based treatment strategies that demonstrate the delivery of high-quality health care in resource-poor settings. He has written extensively on health, human rights, and the consequences of social inequality. He is a member of the American Academy of Arts and Sciences and the Institute of Medicine of the National Academy of Sciences, from which he was the recipient of the 2018 Public Welfare Medal.
He has authored multiple books, including: In the Company of the Poor: Conversations with Dr. Paul Farmer and Fr. Gustavo Gutiérrez, Re-imagining Global Health: An Introduction, and To Repair the World: Paul Farmer Speaks to the Next Generation. His most recent book will be released in November 2020: Fevers, Feuds, and Diamonds: Ebola and the Ravages of History.
Founder/Co-Coordinator, Success Capital
Dumi (they/them) is proudly Pan African and unequivocally non-binary queer feminist working on eliminating the barriers between grassroots experiences and global policymaking. Dumi is the Founder of Success Capital Organisation; a grassroots organisation providing community health referral services and advocates for SRHR of underserved communities. Dumi is the Vice Chair of Gender DynamiX (RSA), a standing international member representative of Amnesty International, a member of USAID-IREX Global Youth Advisory Council and the African Queer Youth Initiative.
Dr. Tedros Adhanom Ghebreyesus
Dr Tedros Adhanom Ghebreyesus was elected WHO Director-General for a five-year term by WHO Member States at the Seventieth World Health Assembly in May 2017. In doing so, he was the first WHO Director-General elected from among multiple candidates by the World Health Assembly, and was the first person from the WHO African Region to head the world’s leading public health agency.
Born in the Eritrean city of Asmara, Dr Tedros graduated from the University of Asmara with a Bachelor of Biology, before earning a Master of Science (MSc) in Immunology of Infectious Diseases from the University of London, a Doctorate of Philosophy (PhD) in Community Health from the University of Nottingham and an Honorary Fellowship from the London School of Hygiene and Tropical Medicine.
Following his studies, Dr Tedros returned to Ethiopia to support the delivery of health services, first working as a field-level malariologist, before heading a regional health service and later serving in Ethiopia’s federal government for over a decade as Minister of Health and Minister of Foreign Affairs.
As Minister of Health from 2005 to 2012, he led a comprehensive reform of the country’s health system, built on the foundation of universal health coverage and provision of services to all people, even in the most remote areas.
Under his leadership, Ethiopia expanded its health infrastructure, developed innovative health financing mechanisms, and expanded its health workforce. A major component of reforms he drove was the creation of a primary health care extension programme that deployed 40 000 female health workers throughout the country. A significant result was an approximate 60% reduction in child and maternal mortality compared to 2000 levels.
As Minister of Foreign Affairs from 2012 to 2016, he elevated health as a political issue nationally, regionally and globally. In this role, he led efforts to negotiate the Addis Ababa Action Agenda, in which 193 countries committed to the financing necessary to achieve the Sustainable Development Goals.
Prior to his election as Director-General of WHO, Dr Tedros held many leadership positions in global health, including as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, Chair of the Roll Back Malaria Partnership, and Co-chair of the Partnership for Maternal, Newborn and Child Health Board.
After taking office as WHO Director-General on 1 July 2017, Dr Tedros initiated the most significant transformation in the Organization’s history, which has generated a wide range of achievements.
Dr. Githinji Gitahi
Group Chief Executive Officer, Amref Health Africa
Dr Githinji Gitahi is the Group CEO of Amref Health Africa, the largest health development international NGO in Africa delivering health access to more than 11 million people in over 35 countries. Dr Gitahi is renown as a leader on the global and regional front with notable achievements including co-chairing the global UHC2030 movement; serving on the newly constituted Commission on African COVID-19 Response; and serving as a member of the Governing Board of Africa CDC among many others. He is a vocal advocate for pro-poor Universal Health Coverage and leads the largest thought leadership convening on the African health agenda.
Focal Point for health and migration, Health Department, IFRC
Working in the Health and Care Department of the International Federation of Red Cross and Red Crescent Societies, Dr Goguadze is a technical focal for community-based programmes related to health and migration, health and climate, HIV, Tuberculosis and Drug Abuse. Medical Doctor, Master in Advances of Sciences in Public Health, Lasha has spent several years as a Federation’s field delegate in Europe and Asia.
Acting CEO, ONE Campaign
While Gayle Smith is on temporary assignment to the US State Department, Tom Hart is serving as acting CEO.
Tom has been with ONE since 2003. Prior to serving as acting CEO, Tom was the North American Executive Director and leads a professional, bipartisan team dedicated to proposing and passing government policies to fight disease, hunger and poverty, mostly in Africa. During this time, ONE has successfully advocated for governments and the private sector to raise a record-setting $14 billion for the Global Fund to Fight AIDS, TB, and Malaria; push for the passage of the BUILD Act to increase private sector investment in Africa; worked with Congress to pass into law the Electrify Africa Act, and more.
Previously, Tom was the Senior Director of Government Relations at ONE. Before joining ONE, Tom was the Director of Government Relations for the Episcopal Church, USA, and an aide to Senators Alan Cranston and Jay Rockefeller.
Lisa M. Hilmi
Executive Director, CORE Group
Lisa Hilmi has over 30 years of global health experience in over 25+ countries, addressing health disparities for women, children, adolescents and communities. As a nurse, researcher, and public health expert, Lisa has worked at multiple levels of global health, in policy, research, emergency relief, disaster, and response, workforce development, health systems strengthening; from local to global levels. She has worked in the Peace Corps in Niger, for the WHO, non-profits, and multiple development, refugee, disaster, and conflict settings, as well as worked on outbreaks and epidemics in multiple countries. As a nurse, Lisa has worked clinically in pediatric hospital, community, academic, and crisis settings, and has held leadership positions in the UN, Sigma Theta Tau International, INGOs, and foundations. She sits on the WHO’s Partnership of Maternal, Newborn, and Child Health (PMNCH) Board of Directors, the Steering Committee for GAVI- the Global Vaccine Initiative, and is a co-chair for the CSO ACT-A COVAX Vaccine Pillar, as well as other review committees.
Deputy Director, APCASO
Jennifer Ho is a feminist and a human rights activist with more than 20 years of experience in working with and advocating for the rights of vulnerable and marginalized populations and communities in Asia and the Pacific. She is currently the Deputy Director of APCASO, a regional civil society network of community-based and non-governmental organizations on health, human rights, and social justice in Asia and the Pacific. Through her various roles as a community organizer, researcher, program implementer, community advocate, trainer, and organizational and funding governing member, she has worked on, and continues to work on issues and challenges relating to the community system strengthening, the right to health, access to essential medicines, gender equality and equity, and sexual and reproductive health rights.
Dr. Jen Kates
Senior Vice President and Director of Global Health & HIV Policy, KFF
Dr. Jen Kates is Senior Vice President and Director of Global Health & HIV Policy at KFF, where she oversees policy analysis and research focused on the U.S. government’s role in global health and on the global and domestic HIV epidemics. Widely regarded as an expert in the field, she regularly publishes and presents on global health and HIV policy issues and is particularly known for her work analyzing donor government investments in global health; assessing and mapping the U.S. government’s global health architecture, programs, and funding; and tracking and analyzing major U.S. HIV programs and financing, and key trends in the HIV epidemic, an area she has been working in for close to thirty years. Prior to joining KFF in 1998, Dr. Kates was a Senior Associate with The Lewin Group, a health care consulting firm, where she focused on HIV policy, strategic planning/health systems analysis, and health care for vulnerable populations. Among other prior positions, she directed the Office of Lesbian, Gay, and Bisexual Concerns at Princeton University.
Dr. Kates has served on numerous federal and private sector advisory committees on global health and HIV issues, including PEPFAR’s Scientific Advisory Board, the NIH Office of AIDS Research Advisory Council, the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT), the board of the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the Governing Council of the International AIDS Society. She is also a lecturer at the Johns Hopkins School of Advanced International Studies.
Dr. Kates received her Ph.D. in Health Policy from George Washington University. She holds a Bachelor’s degree from Dartmouth College, a Master’s degree in Public Affairs from the Princeton School of Public and International Affairs and a Master’s degree in Political Science from the University of Massachusetts.
Deputy Executive Director, Programme, UNFPA
Ms. Keita joined UNFPA in 2006 as Representative in Mauritania, and thereafter served in representative positions in Benin, as well as in DRC and Nigeria (two of UNFPA’s largest programmes globally) before joining the Guinean Government as a Cabinet Minister in 2018. During this time, Ms. Keita successfully led large and complex public health programmes, expanded strategic partnerships and mobilized critical resources to support delivery. While serving with UNFPA, Ms. Keita also acted as United Nations Resident Coordinator in Mauritania, Benin and DRC where she oversaw the United Nations system at the national level. All throughout her career, Ms. Keita has worked extensively on the empowerment of women and youth, inclusive growth, demographic issues, sustainable human development, addressing sexual and reproductive health, as well as gender-based violence in humanitarian settings.
Ms. Keita, who is a fluent in French and Italian, holds a doctorate in Law, a DEA in International Economics and Development Law and a DESS in International Relations from the University of Paris 1 Sorbonne. Ms. Keita is married and the mother of a young adult.
Associate Vice President, Global Health, Save the Children
Irene Koek is the Head of the Department of Global Health at Save the Children/U.S. She joined Save the Children in late July 2020 after more than 30 years with the U.S. Agency for International Development (USAID). Ms. Koek began her career in family planning/reproductive health, and subsequently served in a number of leadership positions at USAID including as the Senior Deputy Assistant Administrator and acting Assistant Administrator for Global Health. She led the development of USAID’s infectious disease strategy in the late 1990s, and helped start up the President’s Malaria Initiative and USAID’s tuberculosis and neglected tropical diseases programs, and later served as USAID’s Global Health Security Agenda lead. From 2010-2014 she was the Director of the Health Office in USAID/Indonesia. Ms. Koek has worked extensively with international partners, including serving as the Chair of the Stop TB Partnership Coordinating Board from 2005-2009 and representing USAID on the Board of Gavi, the Vaccine Alliance for several years.
Dr. Justin Koonin
President, AIDS Council of New South Wales | Co-Chair, UHC2030
Justin Koonin is co-chair of the UHC2030 Steering Committee and the WHO-hosted Social Participation Technical Network, as well as a member of the WHO Strategic and Technical Advisory Committee on HIV, Viral Hepatitis and Sexually Transmitted Infections. At a national level, he is president of ACON (AIDS Council of New South Wales) based in Sydney, Australia.
Justin is a Fellow of the Australian Institute of Company Directors and a member of the Australian Institute of Company Directors Not-for-Profit Chairs Advisory Forum. He is trained as a mathematician, and currently works as an investment analyst. He has also worked as a postdoctoral research associate (at the University of Sydney), and as a consultant in the areas of predictive analytics and data.
Founding President and Editor-in-Chief, Devex
Raj Kumar is the Founding President and Editor-in-Chief at Devex, the media platform for the global development community. He is a media leader and former humanitarian council chair for the World Economic Forum and a member of the Council on Foreign Relations. His work has led him to more than 50 countries, where he has had the honor to meet many of the aid workers and development professionals who make up the Devex community. He is the author of the book "The Business of Changing the World," a go-to primer on the ideas, people, and technology disrupting the aid industry.
Senior Advisor, COVID-19 Response and Pandemic Preparedness, Global Fund
David is the senior advisor for COVID-19 response and pandemic preparedness at the Global Fund. A medical epidemiologist with more than 20 years of global health experience, he has provided technical leadership within the C19RM, Global Fund’s response mechanism for financing national COVID-19 responses in low- and middle-income countries. David has lived and worked in South and Central America, Southeast Asia and the Western Pacific, and Rwanda, Namibia, Tanzania, and Haiti, the latter three countries serving as U.S. CDC country director. Prior to joining the Global Fund, David worked as a senior advisor at the World Health Organization where he led the development of technical guidelines on data standards, data use, and digital health in the Global HIV Programme. He obtained his MD and MPH from Tufts University, a diploma in tropical medicine from the London School, trained in internal medicine at the University of Colorado, and completed an epidemic intelligence service fellowship at the U.S. CDC.
Executive Director, WACI Health
Rosemary W. Mburu, has been a champion for healthy communities for over fifteen years and currently serves as the Executive Director for WACI Health. Mburu is a civil society leader in Africa and has extensively worked on strengthening civil society and community advocacy and campaigning in Africa. Her work contributes to creating political will towards improved health outcomes for all in Africa.
Country Director, Mozambique, Pathfinder International
Riaz Mobaracaly is a proven leader in public health with more than 13 years of experience in the management and implementation of national, provincial, and district level health programs with a specific focus on sexual and reproductive health, maternal and newborn health, and HIV & AIDS. He joined the team in Mozambique in 2013 as director of clinical services and assumed the role of senior country director in 2016.
Before joining Pathfinder, Riaz spent seven years within the Mozambican Ministry of Health in different capacities and has made substantial contributions to the current status of reproductive health outcomes throughout Mozambique. He has worked hard to develop and increase the technical abilities of staff at the community- and health facility-level, serving as the medical chief officer at the district and provincial level for the Sofala Provincial Health Directorate, the director of the Department of Human Capital within the Government of Nampula and the provincial director of health in Nampula.
Chief Executive Officer, Eleanor Crook Foundation
William Moore has served as Chief Executive Officer of the Eleanor Crook Foundation since 2015. In his role as the first CEO and first full-time employee of ECF, he has led the organization in developing an ambitious strategy and investment plan, building partnerships across the global health and development community, and serving as a vocal spokesperson for the issue of global malnutrition. He was formerly Chief Storyteller at the United Nations Millennium Campaign, where he helped coordinate UN country office engagement plans for the Sustainable Development Goals, and worked to highlight the human aspect of data and development. Moore serves on the Board of Directors for Bread for the World and The Alliance to End Hunger, as well as the United Nations Foundation's Global Leadership Council. Additionally, he is the Chair of the Coalition of Philanthropies for Nutrition. A North Carolina native, Moore graduated with top marks from Columbia University with a degree in American Studies.
Dr. Stephanie Psaki
Senior Advisor, Human Rights & Gender Equity, Department of Health and Human Services
Dr. Stephanie Psaki was appointed Senior Advisor on Human Rights and Gender Equity in the Office of Global Affairs in March of 2021. Before joining HHS, Dr. Psaki was Director of the Population Council's Girl Innovation Research and Learning (GIRL) Center, which provides guidance to governments, international organizations, and philanthropies on investing resources to expand opportunities for women and girls globally. Dr. Psaki is a social demographer with expertise in the intersections of gender, health, and education, and she has led numerous studies on these topics. Her research has been published in top academic journals such as The Lancet and Demography, and she has been invited to present to organizations ranging from the National Academy of Sciences to the Women's Funding Network. She holds a Ph.D. in Public Health from the Johns Hopkins Bloomberg School of Public Health, and an M.S. in Population and International Health from the Harvard T.H. Chan School of Public Health.
Chief of Party, USAID Gender Integration Technical Assistance Task Order II, Banyan Global
Victoria Rames a Senior Associate in the Banyan Global Gender Practice with 25 years of experience managing and implementing cross cutting programs related to gender equality and women’s empowerment across a range of sectors. Her technical areas of expertise include gender equality and agriculture, food security, economic growth, health and nutrition, natural resources management, and gender-based violence (GBV) prevention, mitigation, and response. She is the Chief of Party of the USAID ADVANTAGE Gender Integration Technical Assistance II (GITA) Task Order. GITA II provides on-demand, rapid response short-term technical assistance (STTA) to United States Agency for International Development (USAID) missions and bureaus across multiple sectors to reduce the gender and women’s empowerment gaps that impede development outcomes. Under GITA II, Banyan Global carried out 11 COVID- Specific Gender Analyses and developed the Job Aid Tool for USAID Activities: Carrying out a COVID-Specific Gender Analysis.
Co-Founder, Pandemic Action Network
Carolyn Reynolds has been driving change in global health and development and US foreign policy for three decades. She is a Senior Associate with the Global Health Policy Center at the Center for Strategic and International Studies (CSIS) where she is an expert adviser to the CSIS Commission on Strengthening America’s Health Security. Carolyn is also a Distinguished Fellow with The George Institute for Global Health. She has been serving as a senior adviser to international organizations including the Global Financing Facility for Women, Children and Adolescents, World Bank Group, World Health Organization, and the Global Preparedness Monitoring Board. Previously she was Vice President for Policy and Advocacy at PATH, an international non-profit organization supporting health innovation in developing countries, where she led a team of more than 40 staff working across 6 countries to shape evidence-based policies and mobilize political will and resources for women’s and children’s health, epidemic preparedness and global health research and development. Ms. Reynolds also served as manager for external and corporate relations at the World Bank Group, where she led strategic communications and policy advocacy in global health and human development, including the Bank’s efforts to respond to the 2014-16 Ebola crisis in West Africa. She also was a founding Board member and Managing Director of the US Global Leadership Campaign.
Deputy Executive Director, Global Health Advocates
Bruno Rivalan is the Deputy Executive Director of Global Health Advocates where he manages GHA’s advocacy in Paris on TB, Child survival and UHC. Bruno is a board member of CONCORD (European confederation of Relief and Development NGOs), special advisor to the Gavi board member. He is the co-chair of the advocacy track of the Master in Humanitarian Studies at the Institute of International Relations and Strategies- IRIS
Accessibility Consultant, Election Commission of India
Senior Policy and Partnerships Advisor, USAID
Lisa Schechtman is the Senior Policy and Partnerships Advisor in USAID’s Center for Water Security, Sanitation and Hygiene, focusing on partnerships, external engagement, and a range of policy and strategy issues in support of the Agency’s Water for the World initiative. She also serves as the Agency’s representative to the Steering Committee of the global multi-stakeholder Sanitation and Water for All Partnership.
Previously, Lisa spent eight years as the Director of Policy and Advocacy at WaterAid , where she served as a primary liaison between Congress and the U.S. Administration on legislative matters, and chaired the NGO coalition that advocated for the Senator Paul Simon Water for the World Act, which passed Congress unanimously in 2014. Prior to WaterAid, Lisa served in a range of policy, advocacy, campaigning, and technical support roles in the global health and women’s human rights spaces, including roles with the Global AIDS Alliance, Population Action International (PAI), UNAIDS, and Amnesty International. She also served for three years on the Developed Country NGO Delegation to the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Lisa holds a B.A. in English Literature and French Language from Northwestern University, and an M.A. in International Human Rights and Global Health Affairs from the University of Denver.
Dr. Muyiwa Tegbe
Deputy Director, Primary Health Care, PATH
Dr. Muyiwa Tegbe is health policy and health financing expert with significant experience working the United States, sub-Saharan Africa, and southeast Asia. He is currently PATH’s Deputy Director for Primary Health Care serving as a technical lead for ideation, development, and implementation of primary health care programs and interventions by PATH. A medical doctor by training with a strong interest in developing financially sustainable health systems that will deliver improvements in population health outcomes and deliver of system value. Prior to joining PATH, he provided senior advisory support and thought partnership to country decision-makers to design and implement innovative demand and supply-side financing interventions that increase financial risk protection for populations, increase financing for country health systems and optimize health outcomes. Muyiwa has also worked as a consultant to life-sciences and managed care organizations leading evidence generation activities to support better understanding of unmet needs, improve quality of care, improve access to care, assessments to identify fit-for-purpose provider reimbursement models, and broad policy impact analyses. He has also provided advisory support to investor groups interested in making market entry or equity investments in healthcare in LMICs.
Executive Vice President, Rapid and Molecular Diagnostics, Abbott
Andrea Wainer is Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. She was appointed to this role in June 2019.
Andrea joined Abbott in 1997 and served in a variety of roles within our pharmaceuticals business, including divisional vice president and general manager, renal care. She then led our Animal Health business, which was acquired by Zoetis in February 2015. Immediately prior to assuming her current responsibilities, Andrea served as Vice President, Molecular Diagnostics.
In her current role, Andrea leads two innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; the other the world’s leading provider of rapid point-of-care diagnostics. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.
Andrea earned her bachelor’s degree in accounting from the John M. Olin School of Business, Washington University, St. Louis, Missouri, and her Masters in Business Administration from the Kellogg School of Management, Northwestern University in Evanston, Illinois.
Dr. Angela Wakhweya
Senior Director, Health Equity & Rights, CARE
Angela Wakhweya is a senior policy and program administrative leader with over 20 years of progressive experience in public health program management and fiscal monitoring; regulatory oversight, internal policy and procedure development; program development, implementation, monitoring, and evaluation; workshop facilitation, technical assistance and community event planning; staff development, mentoring and supervision. Strong technical background in public health, especially related to HIV/AIDS, malaria, TB and other infectious disease etiology, epidemiology, prevention and care services. Excellent leadership, interpersonal, team-building, presentation, written and oral communication skills.
Dr. Rochelle Walensky
Rochelle P. Walensky, MD, MPH, is the 19th Director of the Centers for Disease Control and Prevention and the ninth Administrator of the Agency for Toxic Substances and Disease Registry. She is an influential scholar whose pioneering research has helped advance the national and global response to HIV/AIDS. Dr. Walensky is also a well-respected expert on the value of testing and treatment of deadly viruses.
Dr. Walensky served as Chief of the Division of Infectious Diseases at Massachusetts General Hospital from 2017-2020 and Professor of Medicine at Harvard Medical School from 2012-2020. She served on the frontline of the COVID-19 pandemic and conducted research on vaccine delivery and strategies to reach underserved communities.
Dr. Walensky is recognized internationally for her work to improve HIV screening and care in South Africa and nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings.
She is a past Chair of the Office of AIDS Research Advisory Council at the National Institutes of Health, Chair-elect of the HIV Medical Association, and previously served as an advisor to both the World Health Organization and the Joint United Nations Programme on HIV/AIDS.
Originally from Maryland, Dr. Walensky received her Bachelor of Arts from Washington University in St. Louis, her Doctor of Medicine from the Johns Hopkins School of Medicine, and her Masters in Public Health from the Harvard School of Public Health.